From GlobeNewswire: 2025-05-26 02:43:00

Guerbet announces changes to its board of directors, including reducing terms to 4 years, appointing two new independent directors, and renewing the mandates of two existing directors. The board now consists of nine members, with Hugues Lecat as Chairman. New directors include Michèle Lesieur, with extensive healthcare leadership experience, and Eric Drapé, a former executive at Teva Pharmaceuticals. The company expresses gratitude to outgoing directors and looks forward to the contributions of the new members. Guerbet is a global leader in medical imaging, offering a range of products and solutions for diagnostic imaging.



Read more at GlobeNewswire: Evolution de la composition du Conseil